Company profile · free preview

Novartis AG

NVS · NYSE · Healthcare · Updated 11/13/2026

Five-year financials

Fiscal year
Revenue
Net income
Diluted EPS
Operating cash flow
Free cash flow
Cash
Total debt

Financials are being prepared.

Want the story behind these numbers? Ask Osiris anything about Novartis AG's filings — free.

Create free account

Novartis AG return on capital (fiscal 2025)

ROIC

18.6%

Return on capital

19.0%

Return on equity

31.0%

Return on assets

13.1%

Gross margin

75.8%

Operating margin

31.1%

Net debt / EBITDA

0.96x

SEC filings

No filings stored yet.

Ask anything about Novartis AG's filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

Compare NVS head-to-head

More Healthcare companies